Back

Plasma extracellular vesicle transcriptome as a dynamic liquid biopsy in acute heart failure

Gokulnath, P.; Spanos, M.; Lehmann, H. I.; Sheng, Q.; Rodosthenous, R.; Chaffin, M.; Varrias, D.; Chatterjee, E.; Hutchins, E.; Li, G.; Daaboul, G.; Rana, F.; Wang, A. M.; Keuren-Jensen, K. V.; Ellinor, P.; Shah, R.; Das, S.

2023-02-23 cardiovascular medicine
10.1101/2023.02.17.23285936 medRxiv
Show abstract

BackgroundAcute decompensation is associated with increased mortality in heart failure (HF) patients, though the underlying etiology remains unclear. Extracellular vesicles (EVs) and their cargo may mark specific cardiovascular physiologic states. We hypothesized that EV transcriptomic cargo, including long non-coding RNAs (lncRNAs) and mRNAs, is dynamic from the decompensated to recompensated HF state, reflecting molecular pathways relevant to adverse remodeling. MethodsWe examined differential RNA expression from circulating plasma extracellular RNA in acute HF patients at hospital admission and discharge alongside healthy controls. We leveraged different exRNA carrier isolation methods, publicly available tissue banks, and single nuclear deconvolution of human cardiac tissue to identify cell and compartment specificity of the topmost significantly differentially expressed targets. EV-derived transcript fragments were prioritized by fold change (-1.5 to + 1.5) and significance (<5% false discovery rate), and their expression in EVs was subsequently validated in 182 additional patients (24 control; 86 HFpEF; 72 HFrEF) by qRT-PCR. We finally examined the regulation of EV-derived lncRNA transcripts in human cardiac cellular stress models. ResultsWe identified 138 lncRNAs and 147 mRNAs (present mostly as fragments in EVs) differentially expressed between HF and control. Differentially expressed transcripts between HFrEF vs. control were primarily cardiomyocyte derived, while those between HFpEF vs. control originated from multiple organs and different (non-cardiomyocyte) cell types within the myocardium. We validated 5 lncRNAs and 6 mRNAs to differentiate between HF and control. Of those, 4 lncRNAs (AC092656.1, lnc-CALML5-7, LINC00989, RMRP) were altered by decongestion, with their levels independent of weight changes during hospitalization. Further, these 4 lncRNAs dynamically responded to stress in cardiomyocytes and pericytes in vitro, with a directionality mirroring the acute congested state. ConclusionCirculating EV transcriptome is significantly altered during acute HF, with distinct cell and organ specificity in HFpEF vs. HFrEF consistent with a multi-organ vs. cardiac origin, respectively. Plasma EV-derived lncRNA fragments were more dynamically regulated with acute HF therapy independent of weight change (relative to mRNAs). This dynamicity was further demonstrated with cellular stress in vitro. Prioritizing transcriptional changes in plasma circulating EVs with HF therapy may be a fruitful approach to HF subtype-specific mechanistic discovery. CLINICAL PERSPECTIVEO_ST_ABSWhat is new?C_ST_ABSWe performed extracellular transcriptomic analysis on the plasma of patients with acute decompensated heart failure (HFrEF and HFpEF) before and after decongestive efforts. Long non-coding RNAs (lncRNAs) within extracellular vesicles (EVs) changed dynamically upon decongestion in concordance with changes within human iPSC-derived cardiomyocytes under stress. In acute decompensated HFrEF, EV RNAs are mainly derived from cardiomyocytes, whereas in HFpEF, EV RNAs appear to have broader, non-cardiomyocyte origins. What are the clinical implications?Given their concordance between human expression profiles and dynamic in vitro responses, lncRNAs within EVs during acute HF may provide insight into potential therapeutic targets and mechanistically relevant pathways. These findings provide a "liquid biopsy" support for the burgeoning concept of HFpEF as a systemic disorder extending beyond the heart, as opposed to a more cardiac-focused physiology in HFrEF.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Circulation: Heart Failure
14 papers in training set
Top 0.1%
22.9%
2
Circulation
66 papers in training set
Top 0.2%
12.9%
3
Journal of Molecular and Cellular Cardiology
39 papers in training set
Top 0.2%
4.9%
4
Journal of the American Heart Association
119 papers in training set
Top 1%
4.9%
5
Circulation: Genomic and Precision Medicine
42 papers in training set
Top 0.4%
4.0%
6
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.1%
4.0%
50% of probability mass above
7
European Heart Journal
16 papers in training set
Top 0.1%
4.0%
8
The American Journal of Cardiology
15 papers in training set
Top 0.6%
3.7%
9
Frontiers in Physiology
93 papers in training set
Top 1%
3.7%
10
Journal of the American College of Cardiology
12 papers in training set
Top 0.2%
2.1%
11
Scientific Reports
3102 papers in training set
Top 53%
1.9%
12
JCI Insight
241 papers in training set
Top 3%
1.7%
13
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.4%
1.7%
14
European Journal of Preventive Cardiology
13 papers in training set
Top 0.5%
1.7%
15
Cardiovascular Research
33 papers in training set
Top 0.6%
1.4%
16
American Journal of Physiology-Heart and Circulatory Physiology
32 papers in training set
Top 0.8%
1.4%
17
iScience
1063 papers in training set
Top 23%
1.1%
18
European Heart Journal - Digital Health
15 papers in training set
Top 0.5%
1.0%
19
BMC Cardiovascular Disorders
14 papers in training set
Top 1%
1.0%
20
eLife
5422 papers in training set
Top 53%
0.9%
21
International Journal of Molecular Sciences
453 papers in training set
Top 12%
0.9%
22
BMC Medicine
163 papers in training set
Top 6%
0.9%
23
JACC: Basic to Translational Science
15 papers in training set
Top 0.4%
0.8%
24
Nature Cardiovascular Research
28 papers in training set
Top 0.5%
0.8%
25
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
0.8%
26
Cell Reports Medicine
140 papers in training set
Top 8%
0.8%
27
British Journal of Anaesthesia
14 papers in training set
Top 0.7%
0.8%
28
Journal of Translational Medicine
46 papers in training set
Top 3%
0.7%
29
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.4%
0.7%
30
Computers in Biology and Medicine
120 papers in training set
Top 5%
0.7%